Abbisko Acquires China Rights to Anti-Immunosuppresive Drug from Boston’s X4 Jul 19, 2019 Life Science
EdiGene, a Beijing CRISPR/Cas9 Editing Company, Sells Knockout Cell Line Library to Abcam Jul 18, 2019 Life Science
Philips acquires Boston start-up Medumo to help hospitals communicate with patients Jul 18, 2019 Life Science
I-Mab Announces IND Approval for Its Proprietary TJC4, A Potentially Differentiated CD47 Antibody, to Initiate Clinical Trials in China Jul 16, 2019 Life Science
Invitae to Acquire Jungla to Advance Genetic Variant Interpretation, Adds Supplemental RNA Analysis to Deliver Deeper, More Informative Results to Patients Jul 12, 2019 Life Science